litlas
ログインアカウント作成

Bo Åhrén

1979–2025 年に発表

別表記
Bo Ahrén
166
論文数
29,416
被引用数
104
h 指数
165
i10 指数

被引用数

Bo Åhrén の年別被引用数1982 年: 被引用 3 件1983 年: 被引用 2 件1984 年: 被引用 3 件1985 年: 被引用 3 件1986 年: 被引用 7 件1987 年: 被引用 17 件1988 年: 被引用 11 件1989 年: 被引用 14 件1990 年: 被引用 7 件1991 年: 被引用 4 件1992 年: 被引用 14 件1993 年: 被引用 18 件1994 年: 被引用 20 件1995 年: 被引用 30 件1996 年: 被引用 18 件1997 年: 被引用 40 件1998 年: 被引用 81 件1999 年: 被引用 78 件2000 年: 被引用 116 件2001 年: 被引用 127 件2002 年: 被引用 186 件2003 年: 被引用 222 件2004 年: 被引用 336 件2005 年: 被引用 324 件2006 年: 被引用 341 件2007 年: 被引用 378 件2008 年: 被引用 363 件2009 年: 被引用 355 件2010 年: 被引用 305 件2011 年: 被引用 336 件2012 年: 被引用 286 件2013 年: 被引用 307 件2014 年: 被引用 311 件2015 年: 被引用 287 件2016 年: 被引用 239 件2017 年: 被引用 186 件2018 年: 被引用 224 件2019 年: 被引用 690 件2020 年: 被引用 593 件2021 年: 被引用 594 件2022 年: 被引用 473 件2023 年: 被引用 323 件2024 年: 被引用 475 件2025 年: 被引用 265 件2026 年: 被引用 9 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,694 件、この内訳の 25.4%イギリス: 引用元論文 712 件、この内訳の 6.7%中国: 引用元論文 606 件、この内訳の 5.7%ドイツ: 引用元論文 589 件、この内訳の 5.5%デンマーク: 引用元論文 570 件、この内訳の 5.4%スウェーデン: 引用元論文 551 件、この内訳の 5.2%カナダ: 引用元論文 505 件、この内訳の 4.8%イタリア: 引用元論文 467 件、この内訳の 4.4%日本: 引用元論文 333 件、この内訳の 3.1%フランス: 引用元論文 332 件、この内訳の 3.1%オーストラリア: 引用元論文 323 件、この内訳の 3%スペイン: 引用元論文 282 件、この内訳の 2.7%
0%25.4%その他 25%

機関

分野

  • Medicine71%
  • Neuroscience12.7%
  • Biochemistry, Genetics and Molecular Biology11%
  • Nursing1.6%
  • Immunology and Microbiology0.8%
  • Agricultural and Biological Sciences0.6%
  • その他2.3%

トピック

  • Diabetes Treatment and Management10.1%
  • Pancreatic function and diabetes7.8%
  • Regulation of Appetite and Obesity4.8%
  • Adipose Tissue and Metabolism4.7%
  • Adipokines, Inflammation, and Metabolic Diseases3.9%
  • Metabolism, Diabetes, and Cancer3.7%
  • その他65%

共著者

全論文

検索で開く
  1. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial

    著者: Bo Åhrén, Luís Masmiquel, Harish Kumar, Mehmet Sargın, Julie Derving Karsbøl, Sanja Hald Jacobsen, Francis Chun Chung Chow - The Lancet Diabetes & Endocrinology 2017 被引用: 476

  2. Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial

    著者: Bo Åhrén, Irl B. Hirsch, Thomas R. Pieber, Chantal Mathieu, Fernando Gómez‐Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jensen, John B. Buse, for the ADJUNCT TWO Investigators - Diabetes Care 2016 被引用: 251

  3. Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

    著者: Bo Åhrén, Stephen L. Atkin, G. Charpentier, Mark Warren, John Wilding, Sune Birch, Anders G. Holst, Lawrence A. Leiter - Diabetes Obesity and Metabolism 2018 被引用: 152

  4. The High-Fat Diet–Fed Mouse

    著者: Maria Sörhede Winzell, Bo Åhrén - Diabetes 2004 被引用: 1,016

  5. Interleukin-6-deficient mice develop mature-onset obesity

    著者: Ville Wallenius, Kristina Wallenius, Bo Åhrén, Mats Rudling, Hans Carlsten, Suzanne L. Dickson, Claes Ohlsson, John‐Olov Jansson - Nature Medicine 2002 被引用: 1,212

  6. Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy

    著者: Matthias H. Tschöp, Rubén Nogueiras, Bo Åhrén - Diabetologia 2023 被引用: 86

  7. Glucose-dependent insulinotropic polypeptide (GIP)

    著者: Timo D. Müller, Alice E. Adriaenssens, Bo Ahrén, Matthias Blüher, Andreas L. Birkenfeld, Jonathan E. Campbell, Matthew P. Coghlan, David D’Alessio, Carolyn F. Deacon, Stefano DelPrato, Jonathan D. Douros, Daniel J. Drucker, N. Burgos, Peter R. Flatt, Brian Finan, Ruth E. Gimeno, Fiona M. Gribble, Matthew R. Hayes, Christian Hölscher, Jens J. Holst, Patrick J. Knerr, Filip K. Knop, Christine M. Kusminski, Arkadiusz Liśkiewicz, Guillaume Mabilleau, Stephanie A. Mowery, Michael A. Nauck, Aaron Novikoff, Frank Reimann, Anna G Roberts, Mette M. Rosenkilde, Ricardo J. Samms, Philip E Scherer, Randy J. Seeley, Kyle W. Sloop, Christian Wolfrum, Denise Wootten, Richard D. DiMarchi, Matthias H. Tschöp - Molecular Metabolism 2025 被引用: 61

  8. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease

    著者: Thomas Nyström, M. Gutniak, Qimin Zhang, Fan Zhang, Jens J. Holst, Bo Åhrén, Åke Sjöholm - American Journal of Physiology-Endocrinology and Metabolism 2004 被引用: 671

  9. Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

    著者: Kristine Færch, Dorte Vistisen, Giovanni Pacini, Signe S. Torekov, Nanna B. Johansen, Daniel R. Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Marit E. Jørgensen, Bo Åhrén, Jens J. Holst - Diabetes 2016 被引用: 229

  10. Autonomic regulation of islet hormone secretion - Implications for health and disease

    著者: Bo Åhrén - Diabetologia 2000 被引用: 900

  11. Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

    著者: M. Gutniak, Cathrine Ørkov, Jens J. Holst, Bo Åhrén, Suad Efendić - New England Journal of Medicine 1992 被引用: 875

  12. Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial

    著者: Daniela Jakubowicz, Julio Wainstein, Zohar Landau, Itamar Raz, Bo Åhrén, Nava Chapnik, Tali Ganz, Miriam Menaged, Maayan Barnea, Yosefa Bar‐Dayan, Oren Froy - Diabetes Care 2017 被引用: 176

  13. Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M)

    著者: Bo Åhrén, Aniceto Leguizamo Dimas, P. Miossec, Stéphane Saubadu, Ronnie Aronson - Diabetes Care 2013 被引用: 171

  14. Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver

    著者: Galyna Bryzgalova, Hui Gao, Bo Åhrén, Juleen R. Zierath, Dana Galuska, Tatiana L. Steiler, Karin Dahlman‐Wright, S. Nilsson, Jan Gustafsson, Suad Efendić, Abdul Waheed Khan - Diabetologia 2006 被引用: 378

  15. HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin

    著者: Bo Åhrén, Susan Johnson, Murray Stewart, Deborah T. Cirkel, Fred Yang, Caroline Perry, Mark N. Feinglos - Diabetes Care 2014 被引用: 226

  16. Surrogate measures of insulin sensitivity vs the hyperinsulinaemic–euglycaemic clamp: a meta-analysis

    著者: Julia Otten, Bo Åhrén, Tommy Olsson - Diabetologia 2014 被引用: 168

  17. High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial

    著者: Daniela Jakubowicz, Julio Wainstein, Bo Åhrén, Yosefa Bar‐Dayan, Zohar Landau, Hadas Rachel Rabinovitz, Oren Froy - Diabetologia 2015 被引用: 138

  18. DPP-4 inhibitors

    著者: Bo Åhrén - Best Practice & Research Clinical Endocrinology & Metabolism 2007 被引用: 203

  19. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes

    著者: Bo Åhrén - Nature Reviews Drug Discovery 2009 被引用: 419

  20. Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro

    著者: Julio Rosenstock, Vivian Fonseca, Jorge Luiz Gross, Robert E. Ratner, Bo Åhrén, Francis C. C. Chow, Fred Yang, Diane Miller, Susan Johnson, Murray Stewart, Lawrence A. Leiter - Diabetes Care 2014 被引用: 205

  21. Differential Islet and Incretin Hormone Responses in MorningVersusAfternoon after Standardized Meal in Healthy Men

    著者: Ola Lindgren, Andrea Mari, Carolyn F. Deacon, Richard D. Carr, Maria Sörhede Winzell, Jenny Vikman, Bo Åhrén - The Journal of Clinical Endocrinology & Metabolism 2009 被引用: 109

  22. Islet Amyloid and Type 2 Diabetes Mellitus

    著者: Jo W.M. Höppener, Bo Åhrén, Cornelis J.M. Lips - New England Journal of Medicine 2000 被引用: 526

  23. Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial

    著者: Daniela Jakubowicz, Julio Wainstein, Bo Åhrén, Zohar Landau, Yosefa Bar‐Dayan, Oren Froy - Diabetes Care 2015 被引用: 167

  24. Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials

    著者: Matteo Monami, Bo Åhrén, Ilaria Dicembrini, Edoardo Mannucci - Diabetes Obesity and Metabolism 2012 被引用: 256